Why is Beta Drugs Ltd falling/rising?

As of 04-Nov, Beta Drugs Ltd is experiencing a decline in its stock price, currently at 1,743.15, which reflects a decrease of 73.45 points or 4.04%. The stock has underperformed its sector by 3.57% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 46.97% compared to the 5-day average. Over the past week, the stock has decreased by 6.86%, while its year-to-date performance shows a decline of 8.67%. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
Broader Market Context: In comparison to the benchmark, the Sensex has only declined by 1.31% over the past week, indicating that Beta Drugs Ltd is underperforming relative to the broader market. While the Sensex has shown a positive return of 2.83% over the past month, Beta Drugs Ltd has experienced a decline of 4.74% in the same period. This trend highlights the stock's struggles in a market that is generally performing better, suggesting that external market conditions may not be favoring Beta Drugs Ltd at this time.